UDC 636: 618.19-002 + 615.036.8
doi: 10.36871/vet.san.hyg.ecol.202302015
Authors
Vladimir G. Tyurin,
All-Russian Research Institute of Veterinary Sanitation, Hygiene and Ecology – Branch of Federal Scientific Center "K.I. Skryabin, Ya. R. Kovalenko All-Russian Research Institute of Experimental Veterinary Medicine", Russian Academy of Sciences, Moscow 123022, Russian Federation; Moscow State Academy of Veterinary Medicine and Biotechnology – MVA named after K.I. Skryabin
Moscow 109472, Russian Federation
Vladimir G. Semenov,
Anna V. Luzova,
Daria E. Biryukova,
Chuvash State Agrarian University, Cheboksary 428003, Russian Federation
Abstract
Currently, animal husbandry is rapidly developing, which often has an adverse effect on animals, violating immunity and reducing the natural resistance of the body. Therefore, cows with high milk productivity are most susceptible to various inflammatory processes, including mastitis. The purpose of this work was the scientific and practical justification of the feasibility of using immunotropic agents of a new generation for the prevention and treatment of cow mastitis. In the first series of experiments, prevention of cow mastitis was carried out with immunotropic drugs Prevention- N-A-M and Prevention-N-B-S, developed by scientists of the Chuvash State Agrarian University, as well as with the drug Mastinol; in the second series of experiments – treatment with drugs Prevention-N-A-M, Prevention-N-B-S, amoxicillin. It has been established that immunotropic drugs contribute to the prevention and treatment of cow mastitis, improve the function of hematopoiesis, metabolism, activate factors of cellular and humoral resistance, reproductive and productive qualities of the body, with a more pronounced Prevention-N-A-M effect.
Keywords
cows, immunotropic drugs, clinical mastitis, immunocorrection of the body, prevention, treatment, milk
